Searchable abstracts of presentations at key conferences in endocrinology

ea0056s26.2 | Cortisol: Too much of a Good Thing | ECE2018

Hypercortisolism and the brain

van der Wee Nic

Background: Alongside various physical symptoms, patients with high levels of cortisol, such as typically found in Cushing’s disease, often display a wide variety of neuropsychiatric symptoms such as depression, psychosis, mania and cognitive impairments. This indicates involvement of the central nervous system in hypercortisolism.Methods: Various neuroimaging approaches can be used to examine the effects of hypercortisolism on the brain. The freque...

ea0081ep950 | Thyroid | ECE2022

Therapeutic plasmapheresis to induce euthyroidism prior to thyroidectomy

Mee Cheng Wee , Kuan YC

Use of therapeutic plasmapheresis in hyperthyroidism is mainly described in thyroid storm when traditional measures fail. Patients with hyperthyroidism who respond poorly or suffer adverse effects to conventional antithyroid therapies, which then need to be stopped, can have persistently high levels of thyroxine and at risk of a full blown thyroid storm. Hence an alternative treatment to achieve euthyroidism followed by thyroidectomy as definitive therapy is vital. We report h...

ea0011p158 | Clinical case reports | ECE2006

Plasma exchange for the prevention of severe thyrotoxic exacerbation following radioactive iodine therapy for Graves hyperthyroidism

Wee A , DeSilva V , Prentice MG

We present 2 patients who developed severe thyrotoxic exacerbation following radioiodine. The first treated by conventional antithyroid therapy, the second was plasma exchanged.Patient A aged 39 male with FT3=28.2 pmol/l (2.5–5.3) FT4=49.0 pmol/l (9.1–23.8) TSH=<0.01 mU/l (0.32–5.0),a large diffuse goitre, thyroid eye disease and asthmatic on inhaled ventolin. He received 3.5 years of carbimazole 40 mg and thyroxine 100 mcg. Thyroxine ...

ea0019p269 | Pituitary | SFEBES2009

The management of microprolactinoma: are we following the guidelines for dopamine agonist withdrawal?

Huda M , Wee J , Kwok H , Lawrence U , Moore R , Scally L , Gibbs C , Tremble J

Background: Dopamine agonist (DA) withdrawal is common in the management of microprolactinoma. Guidelines in 19971 and 20062 suggest that DA should be withdrawn after normoprolactinaemia for 3 years.Aims: To assess DA withdrawal and adherence to guidelines.Methods: We retrospectively examined casenotes from 1997 to 2008. Patients were included with clinical and biochemical evidence of hyperprolactinaemia, and ...

ea0037gp.21.03 | Pituitary – Diagnosis of Cushing's disease | ECE2015

Altered neural processing during emotional faces in remitted Cushing's disease

Andela Cornelie , Hoogendam Janna Marie , Van der Werff Steven , Pannekoek Nienke , Van Steenbergen Henk , Meijer Onno , Van Buchem Mark , Rombouts Serge , Van der Mast Roos , Biermasz Nienke , Van der Wee Nic , Pereira Alberto

Background: Patients with long-term remission of Cushing’s disease (CD) demonstrate residual psychological complaints. At present, it is not known how previous exposure to hypercortisolism affects psychological functioning in the long-term. In foregoing Magnetic Resonance Imaging (MRI) studies, abnormalities of brain structure and resting-state connectivity were demonstrated in patients with long-term remission of CD. However, no data are available on functional alteratio...

ea0070aep44 | Adrenal and Cardiovascular Endocrinology | ECE2020

Etiology and extent of impaired quality of life, fatigue and affective, cognitive, and emotional dysfunction in patients with cushing’s syndrome – The IQFACE-CS study

de Vries Friso , Papakokkinou Eleni , Santos Alicia , van Haalen Femke , Valassi Elena , Biermasz Nienke , Johansson Birgitta , Gómez-Ansón Beatriz , Bauduin Stéphanie , Resmini Eugenia , van der Wee Nic , Pereira Alberto M , Webb Susan , Ragnarsson Oskar

Background: Patients with Cushing’s Syndrome (CS) suffer from a variety of neuropsychiatric and cognitive problems. Following remission, some, but not all of these symptoms resolve. Recent cross-sectional studies in patients with CS show persistent structural and functional brain abnormalities. However, longitudinal studies using magnetic resonance imaging, and a detailed neurocognitive assessment, performed before and after treatment, are not available.<p class="abs...